OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(25)
Publication Date
Release Date
2022
(4)
2023
(3)
2015
(3)
2014
(3)
2013
(3)
2016
(2)
2025
(1)
2021
(1)
2018
(1)
2012
(1)
2011
(1)
2010
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Collagen I triggers directional migration, invasion and matrix remodeling of stroma cells in a 3D spheroid model of endometriosis.
Not available
S-EPMC7892880
|
biostudies-literature
Cite
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Not available
S-EPMC4105321
|
biostudies-literature
Cite
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893
|
biostudies-literature
Cite
Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3157322
|
biostudies-literature
Cite
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3536921
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Not available
S-EPMC3389193
|
biostudies-literature
Cite
Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.
Not available
S-EPMC4549177
|
biostudies-literature
Cite
Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4766028
|
biostudies-literature
Cite
Outcomes of eyes with lesions composed of >50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4306628
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets